The Curry International Tuberculosis Center (CITC) proudly announces the online release of 2022 updates to the 3rd edition of its highly acclaimed guide, Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. The updates reflect evolving expert opinion regarding drug-resistant TB care, including the use of shorter treatment regimens. Read about the updates here.
top of page
Recent Posts
See AllThe Indonesia AIDS Coalition (IAC) and Indonesia for Global Justice (IGJ) have filed a patent opposition for the Tuberculosis (TB) drug Bedaquiline with dispersible tablet formulations (hereinafter, i
330
Calls for strengthening health systems in preparation for the next pandemic have intensified in the wake of COVID-19, with estimates ranging from $15 billion to $50 billion needed annually to scale up
530
The monitoring and evaluation framework of the TB Action Plan for the WHO European Region 2023–2030 includes four new indicators reflecting consistent meaningful engagement of the communities and civi
540
bottom of page